InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Calise Chris. Director active across 1 company, notably Coeptis Therapeutics Holdings, Inc.. Aggregated, 2 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €8k. History available since 23 August 2023. The latest transaction was disclosed on 11 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations